Advantest stock closed at ¥37,030 today after a sharp run in recent weeks, so expectations were high heading into the Q2 2027 report. The headline print did not disappoint. Quarterly revenue reached ¥477,727m and basic earnings per share came in at ¥267.76, backed by what management called record gross and operating margins.
Short term traders are focused on whether that kind of profitability can survive component inflation and capacity strain. Longer term holders are weighing those same pressures against a business that now carries a rich 46.6x P/E and a discounted cash flow estimate well below the current share price.
Love Advantest's record margins but worried about paying 46.6x P/E for a stock trading above its discounted cash flow estimate? Take a look at our screener of companies that pair strong fundamentals with more grounded pricing in the 15 high quality undervalued stocks.
Q2 2027 Earnings Summary
- Revenue (Q2 2027 vs. Q2 2026): ¥477,727m vs. ¥262,957m (up 81.7%)
- Net Income, Excl. Extra Items (Q2 2027 vs. Q2 2026): ¥193,303m vs. ¥79,633m (up 142.8%)
- Basic EPS (Q2 2027 vs. Q2 2026): ¥267.76 vs. ¥109.03 (up 145.5%)
- Trailing Net Profit Margin (TTM, Q2 2027 vs. prior year): 39.6% vs. 26.8% (higher margin level year-on-year)
Advantest is already talking about doubling tester capacity again. Ask Charlie what Advantest’s 20k capacity push could mean.
Advantest capacity story meets hard execution tests
For the bullish capacity story to hold, Advantest needs more than strong headlines. It needs proof that output is really scaling in line with rising test demand.
"The main thing that has to go right is that Advantest successfully scales V93000 and related capacity, including buffer capacity, to match higher test content per device and sustained AI-driven demand without becoming a bottleneck for key customers."
Management now reports a ramp from roughly 5,000 systems toward 10,000, raised SoC tester guidance, and a 28% H1 to H2 revenue step up tied directly to higher shipments. Capacity execution is tracking the bullish script, even if the exact 10,000 timing is still pending.
Bear case on margins and memory still on the table
Bears worry less about demand and more about what happens to Advantest profitability and memory exposure once early tailwinds fade.
"Advantest highlights that recent record net margins included the benefit of a one off inventory obsolescence reversal and are facing pressure from higher bill of materials costs, especially sharply higher DRAM prices used in its testers."
Record gross and operating margins, plus upgraded full year guidance, show no visible crack yet. Management still flags DDR and HBM inflation and the roll off of that inventory benefit, and memory tester strength is concentrated in Q4, so the cost and share worries remain live rather than resolved.
One Narrative disagrees with today's price. → See where this Narrative says Advantest should trade.
Hunt For Mispriced Cash Flows
Advantest just showed how strong execution can translate into results when expectations and valuation are already stretched. The real opportunity is finding stocks that could be undervalued before the wider market pays attention.
- Company 1 - 42% below our estimate - turns used car inflows into recurring high margin service relationships across a broad store network.
- Company 2 - 49% below our estimate - sells PET molding lines that customers standardize on for integrated machines, molds, and follow on parts.
- Company 3 - 47% below our estimate - builds HR platforms that become the default system of record after employers consolidate hiring and payroll tools.
Three companies from the same screener. Open every one of the 15 undervalued companies on it →
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com